Eurobiomed H1 2026 review: nearly €250 M mobilised by the HealthTech industry in Southern France

Nearly €250 M mobilised in H1 2026 by Eurobiomed members, including €228.8 M in private funding and €18.8 M in public funding. Biotechs account for the majority of the funds raised, capturing 60.5% of the amounts, ahead of medtechs (26%) and digital health (13.5%). Intensive support activity by Eurobiomed in H1 2026: 49 R&D projects […]
6th Life Sciences Afterwork organised by Team Nice Côte d’Azur

(c) All rights reserved The French Riviera healthcare ecosystem came together in Nice on 16 July for the 6th Life Sciences Afterwork, held under the theme “Connecting Innovators, Old & New”, to strengthen connections between startups, researchers, investors and healthcare innovation players. Many thanks to Circum Life Sciences for hosting this edition at its premises. […]
Follow Health (Nice) joins European software group Orisha

Follow Health, a software company specialising in solutions for medical specialists and surgeons, has joined Orisha, a European group specialising in vertical business software. The transaction was announced as part of three acquisitions unveiled by Orisha on 30 June 2026. The company, which has been headquartered in Nice, at the heart of the Arenas international […]
Team Nice Côte d’Azur at the Van Lanschot Kempen Life Sciences Conference 2026

Team Nice Côte d’Azur will attend the Van Lanschot Kempen Life Sciences Conference in Amsterdam on April 15-16, a key gathering for global institutional investors and European life sciences executives. Sana Bouyahia, Head of Project Development – Health & Sports, will represent the territory and be available for one-to-one meetings. Make an appointment with Sana […]
Launch of the AZUR Territorial Research Entity to advance clinical research on the French Riviera

On March 31, 2026, Nice University Hospital and Cannes Simone Veil Hospital announced the signing of the founding agreement establishing the AZUR Territorial Research Entity. This marks a new phase in the development of clinical research at the territorial level. Nice University Hospital will lead the initiative in its capacity as the coordinating institution of […]
BIO-Europe Spring 2026 : meet with Team Nice Côte d’Azur

Showcasing a Scalable European Biotech Ecosystem Team Nice Côte d’Azur will participate in BIO-Europe Spring 2026 from March 23-25 in Lisbon, represented by Sana Bouyahia, Head of Project Development Health & Sports. The participation aims to showcase the region’s biotech innovation capabilities and explore partnership opportunities with international players. 👉 Book a meeting with Sana […]
Eurobiomed: more than €300 million secured in 2025 in the Sud and Occitanie regions by Eurobiomed member healthcare companies

Eurobiomed, the leading cluster for innovation and industrialisation among healthcare companies in Southern France, supported 22 R&D projects in 2025, resulting in €142 million in public funding secured for its member companies in the Sud and Occitanie regions. In 2025, HealthTech companies in the Sud and Occitanie regions secured €309 million in private funding, including […]
Artificial intelligence: Team Nice Côte d’Azur mobilized for an AI Business Tour and WAICF 2026

From 10 to 13 February 2026, Team Nice Côte d’Azur is mobilizing to promote the territory in the field of artificial intelligence. Alongside risingSUD and its regional partners, Jean-François Chapperon and Stefano Cimmarusti are taking part in the AI Business Tour, with the hosting in Nice on 11 February of more than 50 international decision-makers […]
New medical governance at CHU de Nice

Professor Nicolas Chevalier (on the right in the photo) becomes President of the Medical Committee (CME) of the CHU de Nice. He brings more than twenty years of experience within the hospital. From 2022 until September 2025, he headed the Digestive – Urology – Transplant Surgery, Endocrinology and Nutrition division. Doctor Stéphane Litrico (on the […]
Nice University Hospital (CHU): a living laboratory of hospital transformation

(c) CHU de Nice – All rights reserved Massive and targeted investmentsNice University Hospital has committed €77 million in 2023 and then €63.7 million in 2024. Planned investments reach €64 million in 2025. Major hospital projects relaunchedThe Pasteur 2 Hospital – phase 2 represents a €170 million project for 30,000 m² dedicated to critical care, […]